Assessment of somatic symptom disorder with SSS-CN
Diagnostic TestSSS-CN questionnaire is used to assess the presence and severity of the somatic symptoms
NCT Number: NCT04815863
With the rapid aging and worsening psychological problems worldwide, the special focus on somatic symptom and other psychological diseases of the older population is needed. However, there is no research comparing the incidence of somatic symptom between elderly and non-elderly, and clinical relevance with somatic symptom is uncertain. The study aims to clarify the prevalence of somatic symptom, depression and anxiety disorders in China, to compare physical and psychological difference between the elderly and non-elderly and to explore risk factors for somatic symptom in the elderly.
Looking for future studies?
Notify Me18 year–100 year
All sexes
Observational
Renji Hospital, Shanghai, Shanghai Municipality, China
With the steadily increasing of life expectancy, the aging people is expected to 2 billion by 2050, which brings the deeper demand on the quality of life improvement. The psychological problems is an important factor affecting the quality of life. As reported, 73.6% of urban residents were with mental sub-health, indicating that psychological problem has grown into inevitable issues in hindering healthy development. The elderly, compared with the non-elderly, have unique social and biological characteristics, so psychological problem of the older population deserves special focus. Literatures have investigated aged people with depression or anxiety disorder, but somatic symptom in elderly have rarely been addressed. Somatic symptom disorder prevalence in elderly in European ranged from 0-13.5%. However, there is no research comparing the incidence of somatic symptom, anxiety and depression between elderly and non-elderly and revealing the prevalence of somatic symptom under Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria.
Investigators use Somatic Symptom Scale-China (SSS-CN) questionnaire to assess the presence and severity of the symptoms. Patient Heath Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder Screener (GAD-7) are used to evaluate depression and anxiety disorder respectively. The study aims to clarify the prevalence of somatic symptom, depression and anxiety disorders in China, to compare physical and psychological difference between the elderly and non-elderly and to explore risk factors for somatic symptom in the elderly.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
SSS-CN questionnaire is used to assess the presence and severity of the somatic symptoms
PHQ-9 questionnaire is used to assess the presence and severity of the depressive symptoms
GAD-7 questionnaire is used to assess the presence and severity of the anxiety disorder
Time frame: Within 24 hours of the questionnaire completion.
The scores of Somatic Symptom Scale-China (SSS-CN) questionnaire were recorded. The score higher than 20 was taken as somatic symptom disorder. Percentage of somatic symptom disorder in elderly and in non-elderly were analyzed.
Time frame: Within 24 hours of the questionnaire completion.
anxiety disorder were assessed by Generalized Anxiety Disorder-7 (GAD-7). The percentage of anxiety disorder among the participants with somatic symptoms disorder were analyzed.
Time frame: Within 24 hours of the questionnaire completion.
Depressive disorder were assessed by Patient Health Questionnaire-9 (PHQ-9). The percentage of depressive disorder among the participants with somatic symptoms disorder were analyzed.
RenJi Hospital
Other
A Comparison of Somatic Symptom Among Elderly and Non-elderly in Chinese Community-Dwelling People
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07292064
Anxiety Disorders, Behavior
Yozgat, Turkey (Türkiye)
View Trial DetailsNCT03513185
Mental Disorders, Somatization Disorder
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT01903096
Anxiety Disorders, Depressive Disorder
Madrid, Spain
View Trial DetailsNCT02346071
Medically Unexplained Symptoms, Mental Disorders
Aarhus, Denmark
View Trial Details